GBIO
Generation Bio Co.
Company Overview
| Mkt Cap | $38.73M | Price | $5.51 |
| Volume | 60.11K | Change | +0.18% |
| P/E Ratio | -0.3 | Open | $5.52 |
| Revenue | $19.9M | Prev Close | $5.50 |
| Net Income | $-131.7M | 52W Range | $3.00 - $25.70 |
| Div Yield | N/A | Target | $11.00 |
| Overall | 42 | Value | 60 |
| Quality | 31 | Technical | 36 |
No chart data available
Stock Overview
Updated DailyGeneration Bio Co. (GBIO) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $5.51 with a market capitalization of $38.73 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 31.
Today's trading session shows GBIO with a volume of 60K shares. The stock opened up 0.35% from yesterday's close of $5.50. Current analyst estimates project earnings of $-9.69 per share for this year, with next year targeting $-6.91.
GBIO demonstrates concerning technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for GBIO include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 99.6%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 02:00 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GBIO | $5.51 | +0.2% | 60.11K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |